{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:38:18Z","timestamp":1787071098130,"version":"build-2736575974"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI123047"],"award-info":[{"award-number":["R01AI123047"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI111943"],"award-info":[{"award-number":["R01AI111943"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-67188-4","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T07:04:01Z","timestamp":1765523041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Concurrent TB and HIV therapies control TB reactivation during co-infection but not chronic immune activation"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8297-6634","authenticated-orcid":false,"given":"Riti","family":"Sharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindu","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Shivanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2373-7921","authenticated-orcid":false,"suffix":"Jr.","given":"Edward J.","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannan","family":"Hall-Ursone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanlin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9545-4982","authenticated-orcid":false,"given":"Shabaana A.","family":"Khader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1241-4705","authenticated-orcid":false,"given":"Jyothi","family":"Rengarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smriti","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5809-5407","authenticated-orcid":false,"given":"Hulin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3521-1257","authenticated-orcid":false,"given":"Deepak","family":"Kaushal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"67188_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46570-5","volume":"9","author":"NS Wong","year":"2019","unstructured":"Wong, N. S. et al. A longitudinal study on latent TB infection screening and its association with TB incidence in HIV patients. Sci. Rep. 9, 10093 (2019).","journal-title":"Sci. Rep."},{"key":"67188_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4361-0","volume":"19","author":"A Dravid","year":"2019","unstructured":"Dravid, A. et al. Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India. BMC Infect. Dis. 19, 714 (2019).","journal-title":"BMC Infect. Dis."},{"key":"67188_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016961","volume":"8","author":"A Ahmed","year":"2018","unstructured":"Ahmed, A., Mekonnen, D., Shiferaw, A. M., Belayneh, F. & Yenit, M. K. Incidence and determinants of tuberculosis infection among adult patients with HIV attending HIV care in north-east Ethiopia: a retrospective cohort study. BMJ Open 8, e016961 (2018).","journal-title":"BMJ Open"},{"key":"67188_CR4","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1097\/QAD.0000000000000705","volume":"29","author":"E Liu","year":"2015","unstructured":"Liu, E. et al. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy. AIDS 29, 1391\u20131399 (2015).","journal-title":"AIDS"},{"key":"67188_CR5","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","volume":"20","author":"SD Lawn","year":"2006","unstructured":"Lawn, S. D., Myer, L., Bekker, L. G. & Wood, R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS 20, 1605\u20131612 (2006).","journal-title":"AIDS"},{"key":"67188_CR6","doi-asserted-by":"publisher","first-page":"e1001270","DOI":"10.1371\/journal.pmed.1001270","volume":"9","author":"AB Suthar","year":"2012","unstructured":"Suthar, A. B. et al. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med. 9, e1001270 (2012).","journal-title":"PLoS Med."},{"key":"67188_CR7","doi-asserted-by":"publisher","first-page":"e0262720","DOI":"10.1371\/journal.pone.0262720","volume":"17","author":"N Adhikari","year":"2022","unstructured":"Adhikari, N. et al. Prevalence and associated risk factors for tuberculosis among people living with HIV in Nepal. PLoS One 17, e0262720 (2022).","journal-title":"PLoS One"},{"key":"67188_CR8","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1056\/NEJMoa1507198","volume":"373","author":"C Danel","year":"2015","unstructured":"Danel, C. et al. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N. Engl. J. Med. 373, 808\u2013822 (2015).","journal-title":"N. Engl. J. Med."},{"key":"67188_CR9","doi-asserted-by":"publisher","first-page":"e1080","DOI":"10.1016\/S2214-109X(17)30372-8","volume":"5","author":"A Badje","year":"2017","unstructured":"Badje, A. et al. Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial. Lancet Glob. Health 5, e1080\u2013e1089 (2017).","journal-title":"Lancet Glob. Health"},{"key":"67188_CR10","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S0140-6736(14)60162-8","volume":"384","author":"MX Rangaka","year":"2014","unstructured":"Rangaka, M. X. et al. Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial. Lancet 384, 682\u2013690 (2014).","journal-title":"Lancet"},{"key":"67188_CR11","doi-asserted-by":"publisher","first-page":"e1003875","DOI":"10.1371\/journal.pmed.1003875","volume":"18","author":"FC Semitala","year":"2021","unstructured":"Semitala, F. C. et al. Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial. PLoS Med. 18, e1003875 (2021).","journal-title":"PLoS Med."},{"key":"67188_CR12","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1097\/QAD.0000000000003508","volume":"37","author":"LH Chaisson","year":"2023","unstructured":"Chaisson, L. H. et al. Viral suppression among adults with HIV receiving routine dolutegravir-based antiretroviral therapy and 3\u200amonths weekly isoniazid-rifapentine. AIDS 37, 1097\u20131101 (2023).","journal-title":"AIDS"},{"key":"67188_CR13","doi-asserted-by":"crossref","unstructured":"Sharan, R. et al. Isoniazid and rifapentine treatment effectively reduces persistent M. tuberculosis infection in macaque lungs. J. Clin. Invest. 132, e161564 (2022).","DOI":"10.1172\/JCI161564"},{"key":"67188_CR14","doi-asserted-by":"crossref","unstructured":"Bucsan, A. N. et al. Mechanisms of reactivation of latent tuberculosis infection due to SIV co-infection. J. Clin. Invest. 129, 5254\u20135260 (2019).","DOI":"10.1172\/JCI125810"},{"key":"67188_CR15","doi-asserted-by":"crossref","unstructured":"Sharan, R. et al. Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis\/SIV coinfection model. J. Clin. Invest. 132, e153090 (2022).","DOI":"10.1172\/JCI153090"},{"key":"67188_CR16","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1093\/infdis\/jix625","volume":"217","author":"MJ Kuroda","year":"2018","unstructured":"Kuroda, M. J. et al. High turnover of tissue macrophages contributes to tuberculosis reactivation in simian immunodeficiency virus-infected Rhesus Macaques. J. Infect. Dis. 217, 1865\u20131874 (2018).","journal-title":"J. Infect. Dis."},{"key":"67188_CR17","doi-asserted-by":"publisher","first-page":"E5636","DOI":"10.1073\/pnas.1611987113","volume":"113","author":"TW Foreman","year":"2016","unstructured":"Foreman, T. W. et al. CD4+ T-cell-independent mechanisms suppress reactivation of latent tuberculosis in a macaque model of HIV coinfection. Proc. Natl. Acad. Sci. USA 113, E5636\u2013E5644 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67188_CR18","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.tim.2020.03.015","volume":"28","author":"R Sharan","year":"2020","unstructured":"Sharan, R. et al. Chronic immune activation in TB\/HIV co-infection. Trends Microbiol. 28, 619\u2013632 (2020).","journal-title":"Trends Microbiol."},{"key":"67188_CR19","doi-asserted-by":"crossref","unstructured":"Ganatra, S. R. et al. Anti-retroviral therapy does not reduce tuberculosis reactivation in a tuberculosis-HIV co-infection model. J. Clin. Invest. 130, 5171\u20135179 (2020).","DOI":"10.1172\/JCI136502"},{"key":"67188_CR20","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1172\/JCI136502","volume":"130","author":"SR Ganatra","year":"2020","unstructured":"Ganatra, S. R. et al. Antiretroviral therapy does not reduce tuberculosis reactivation in a tuberculosis-HIV coinfection model. J. Clin. Invest. 130, 5171\u20135179 (2020).","journal-title":"J. Clin. Invest."},{"key":"67188_CR21","doi-asserted-by":"crossref","unstructured":"Sharan, R. et al. Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a tuberculosis\/simian immunodeficiency virus coinfection model. J. Clin. Invest. 132, e153090 (2021).","DOI":"10.1172\/JCI153090"},{"key":"67188_CR22","doi-asserted-by":"crossref","unstructured":"Singh, B. et al. Inhibition of indoleamine dioxygenase leads to better control of tuberculosis adjunctive to chemotherapy. JCI Insight. 8, e163101 (2023).","DOI":"10.1172\/jci.insight.163101"},{"key":"67188_CR23","doi-asserted-by":"crossref","unstructured":"Singh, B. et al. Indoleamine-2,3-dioxygenase inhibition improves immunity and is safe for concurrent use with cART during Mtb\/SIV coinfection. JCI Insight. 9, e179317 (2024).","DOI":"10.1172\/jci.insight.179317"},{"key":"67188_CR24","doi-asserted-by":"crossref","unstructured":"Shanmugasundaram, U. et al. Pulmonary Mycobacterium tuberculosis control associates with CXCR3- and CCR6-expressing antigen-specific Th1 and Th17 cell recruitment. JCI Insight. 5, e137858 (2020).","DOI":"10.1172\/jci.insight.137858"},{"key":"67188_CR25","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.4049\/jimmunol.1401151","volume":"193","author":"CL Arlehamn","year":"2014","unstructured":"Arlehamn, C. L. et al. Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features. J. Immunol. 193, 2931\u20132940 (2014).","journal-title":"J. Immunol."},{"key":"67188_CR26","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.4049\/jimmunol.0903058","volume":"184","author":"A Gosselin","year":"2010","unstructured":"Gosselin, A. et al. Peripheral blood CCR4+CCR6+ and CXCR3+CCR6+CD4+ T cells are highly permissive to HIV-1 infection. J. Immunol. 184, 1604\u20131616 (2010).","journal-title":"J. Immunol."},{"key":"67188_CR27","doi-asserted-by":"publisher","first-page":"e6984","DOI":"10.1371\/journal.pone.0006984","volume":"4","author":"R Dawson","year":"2009","unstructured":"Dawson, R. et al. Immunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis. PLoS ONE 4, e6984 (2009).","journal-title":"PLoS ONE"},{"key":"67188_CR28","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1164\/rccm.201006-0963PP","volume":"183","author":"S Schwander","year":"2011","unstructured":"Schwander, S. & Dheda, K. Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection. Am. J. Respir. Crit. Care Med. 183, 696\u2013707 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"67188_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1600-0684.2011.00485.x","volume":"40","author":"S Mehra","year":"2011","unstructured":"Mehra, S. et al. Reactivation of latent tuberculosis in rhesus macaques by coinfection with simian immunodeficiency virus. J. Med. Primatol. 40, 233\u2013243 (2011).","journal-title":"J. Med. Primatol."},{"key":"67188_CR30","doi-asserted-by":"publisher","first-page":"706723","DOI":"10.3389\/fimmu.2021.706723","volume":"12","author":"R Sharan","year":"2021","unstructured":"Sharan, R., Singh, D. K., Rengarajan, J. & Kaushal, D. Characterizing early T cell responses in nonhuman primate model of tuberculosis. Front. Immunol. 12, 706723 (2021).","journal-title":"Front. Immunol."},{"key":"67188_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57090-4","volume":"16","author":"DK Singh","year":"2025","unstructured":"Singh, D. K. et al. Prevention of tuberculosis in cynomolgus macaques by an attenuated Mycobacterium tuberculosis vaccine candidate. Nat. Commun. 16, 1957 (2025).","journal-title":"Nat. Commun."},{"key":"67188_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.micinf.2019.10.001","volume":"22","author":"G Li","year":"2020","unstructured":"Li, G. et al. Anti-tuberculosis (TB) chemotherapy dynamically rescues Th1 and CD8+ T effector levels in Han Chinese pulmonary TB patients. Microbes Infect. 22, 119\u2013126 (2020).","journal-title":"Microbes Infect."},{"key":"67188_CR33","doi-asserted-by":"publisher","first-page":"745483","DOI":"10.1155\/2012\/745483","volume":"2012","author":"YV Cavalcanti","year":"2012","unstructured":"Cavalcanti, Y. V., Brelaz, M. C., Neves, J. K., Ferraz, J. C. & Pereira, V. R. Role of TNF-alpha, IFN-gamma, and IL-10 in the development of pulmonary tuberculosis. Pulm. Med. 2012, 745483 (2012).","journal-title":"Pulm. Med."},{"key":"67188_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/srep01809","volume":"3","author":"N Allie","year":"2013","unstructured":"Allie, N. et al. Prominent role for T cell-derived tumour necrosis factor for sustained control of Mycobacterium tuberculosis infection. Sci. Rep. 3, 1809 (2013).","journal-title":"Sci. Rep."},{"key":"67188_CR35","doi-asserted-by":"crossref","unstructured":"Olsen, A. et al. Targeting Mycobacterium tuberculosis tumor necrosis factor alpha-downregulating genes for the development of antituberculous vaccines. mBio 7, e01023-15 (2016).","DOI":"10.1128\/mBio.01023-15"},{"key":"67188_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cyto.2016.08.003","volume":"101","author":"AK Mehta","year":"2018","unstructured":"Mehta, A. K., Gracias, D. T. & Croft, M. TNF activity and T cells. Cytokine 101, 14\u201318 (2018).","journal-title":"Cytokine"},{"key":"67188_CR37","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/infdis\/jit265","volume":"208","author":"KM Pollock","year":"2013","unstructured":"Pollock, K. M. et al. T-cell immunophenotyping distinguishes active from latent tuberculosis. J. Infect. Dis. 208, 952\u2013968 (2013).","journal-title":"J. Infect. Dis."},{"key":"67188_CR38","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nm.2299","volume":"17","author":"A Harari","year":"2011","unstructured":"Harari, A. et al. Dominant TNF-\u03b1+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat. Med. 17, 372\u2013376 (2011).","journal-title":"Nat. Med."},{"key":"67188_CR39","doi-asserted-by":"crossref","unstructured":"Ogongo, P. et al. High-parameter phenotypic characterization reveals a subset of human Th17 cells that preferentially produce IL17 against M. tuberculosis antigen. Front. Immunol. 15, 1378040 (2024).","DOI":"10.3389\/fimmu.2024.1378040"},{"key":"67188_CR40","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1084\/jem.20180325","volume":"215","author":"L Moreira-Teixeira","year":"2018","unstructured":"Moreira-Teixeira, L., Mayer-Barber, K., Sher, A. & O\u2019Garra, A. Type I interferons in tuberculosis: Foe and occasionally friend. J. Exp. Med. 215, 1273\u20131285 (2018).","journal-title":"J. Exp. Med."},{"key":"67188_CR41","doi-asserted-by":"publisher","first-page":"5536","DOI":"10.1016\/j.cell.2023.11.002","volume":"186","author":"DI Kotov","year":"2023","unstructured":"Kotov, D. I. et al. Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis. Cell 186, 5536\u20135553 e5522 (2023).","journal-title":"Cell"},{"key":"67188_CR42","doi-asserted-by":"crossref","unstructured":"Esaulova, E. et al. The immune landscape in tuberculosis reveals populations linked to disease and latency. Cell Host Microbe 29, 165-178.e168 (2020).","DOI":"10.1016\/j.chom.2020.11.013"},{"key":"67188_CR43","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1172\/JCI130546","volume":"130","author":"NR Scott","year":"2020","unstructured":"Scott, N. R. et al. S100A8\/A9 regulates CD11b expression and neutrophil recruitment during chronic tuberculosis. J. Clin. Invest. 130, 3098\u20133112 (2020).","journal-title":"J. Clin. Invest."},{"key":"67188_CR44","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nature09247","volume":"466","author":"MP Berry","year":"2010","unstructured":"Berry, M. P. et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973\u2013977 (2010).","journal-title":"Nature"},{"key":"67188_CR45","doi-asserted-by":"crossref","unstructured":"Ahmed, M. et al. Immune correlates of tuberculosis disease and risk translate across species. Sci. Transl. Med. 12, eaay0233 (2020).","DOI":"10.1126\/scitranslmed.aay0233"},{"key":"67188_CR46","doi-asserted-by":"publisher","first-page":"110983","DOI":"10.1016\/j.celrep.2022.110983","volume":"39","author":"S Akter","year":"2022","unstructured":"Akter, S. et al. Mycobacterium tuberculosis infection drives a type I IFN signature in lung lymphocytes. Cell Rep. 39, 110983 (2022).","journal-title":"Cell Rep."},{"key":"67188_CR47","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.chom.2024.11.008","volume":"32","author":"CS Chowdhury","year":"2024","unstructured":"Chowdhury, C. S. et al. Type I IFN-mediated NET release promotes Mycobacterium tuberculosis replication and is associated with granuloma caseation. Cell Host Microbe 32, 2092\u20132111 e2097 (2024).","journal-title":"Cell Host Microbe"},{"key":"67188_CR48","doi-asserted-by":"publisher","first-page":"e401","DOI":"10.1016\/S2352-3018(20)30032-1","volume":"7","author":"KE Dooley","year":"2020","unstructured":"Dooley, K. E. et al. Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1\/2 trial. Lancet HIV 7, e401\u2013e409 (2020).","journal-title":"Lancet HIV"},{"key":"67188_CR49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1600-0684.2012.00536.x","volume":"41","author":"D Kaushal","year":"2012","unstructured":"Kaushal, D., Mehra, S., Didier, P. J. & Lackner, A. A. The non-human primate model of tuberculosis. J. Med Primatol. 41, 191\u2013201 (2012).","journal-title":"J. Med Primatol."},{"key":"67188_CR50","doi-asserted-by":"publisher","first-page":"a018564","DOI":"10.1101\/cshperspect.a018564","volume":"4","author":"CA Scanga","year":"2014","unstructured":"Scanga, C. A. & Flynn, J. L. Modeling tuberculosis in nonhuman primates. Cold Spring Harb. Perspect. Med 4, a018564 (2014).","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"67188_CR51","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/imr.12258","volume":"264","author":"JL Flynn","year":"2015","unstructured":"Flynn, J. L., Gideon, H. P., Mattila, J. T. & Lin, P. L. Immunology studies in non-human primate models of tuberculosis. Immunol. Rev. 264, 60\u201373 (2015).","journal-title":"Immunol. Rev."},{"key":"67188_CR52","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.immuni.2022.04.004","volume":"55","author":"HP Gideon","year":"2022","unstructured":"Gideon, H. P. et al. Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control. Immunity 55, 827\u2013846.e810 (2022).","journal-title":"Immunity"},{"key":"67188_CR53","doi-asserted-by":"publisher","first-page":"103233","DOI":"10.1016\/j.ebiom.2021.103233","volume":"64","author":"CAM Mpande","year":"2021","unstructured":"Mpande, C. A. M. et al. Immune profiling of Mycobacterium tuberculosis-specific T cells in recent and remote infection. EBioMedicine 64, 103233 (2021).","journal-title":"EBioMedicine"},{"key":"67188_CR54","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/imcb.12275","volume":"97","author":"C Counoupas","year":"2019","unstructured":"Counoupas, C. & Triccas, J. A. The generation of T-cell memory to protect against tuberculosis. Immunol. Cell Biol. 97, 656\u2013663 (2019).","journal-title":"Immunol. Cell Biol."},{"key":"67188_CR55","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1182\/bloodadvances.2017011346","volume":"2","author":"A Gehad","year":"2018","unstructured":"Gehad, A. et al. A primary role for human central memory cells in tissue immunosurveillance. Blood Adv. 2, 292\u2013298 (2018).","journal-title":"Blood Adv."},{"key":"67188_CR56","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/s41423-021-00694-9","volume":"18","author":"M Robert","year":"2021","unstructured":"Robert, M. & Miossec, P. Reactivation of latent tuberculosis with TNF inhibitors: critical role of the beta 2 chain of the IL-12 receptor. Cell Mol. Immunol. 18, 1644\u20131651 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"67188_CR57","doi-asserted-by":"crossref","unstructured":"Mundra, A. et al. Pathogenicity of type I interferons in Mycobacterium tuberculosis. Int. J. Mol. Sci. 24, 3919 (2023).","DOI":"10.3390\/ijms24043919"},{"key":"67188_CR58","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","volume":"15","author":"F McNab","year":"2015","unstructured":"McNab, F., Mayer-Barber, K., Sher, A., Wack, A. & O\u2019Garra, A. Type I interferons in infectious disease. Nat. Rev. Immunol. 15, 87\u2013103 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"67188_CR59","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/cmi.2016.25","volume":"14","author":"KD Mayer-Barber","year":"2017","unstructured":"Mayer-Barber, K. D. & Yan, B. Clash of the cytokine titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses. Cell Mol. Immunol. 14, 22\u201335 (2017).","journal-title":"Cell Mol. Immunol."},{"key":"67188_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19412-6","volume":"11","author":"L Moreira-Teixeira","year":"2020","unstructured":"Moreira-Teixeira, L. et al. Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis. Nat. Commun. 11, 5566 (2020).","journal-title":"Nat. Commun."},{"key":"67188_CR61","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1007\/s13238-014-0077-5","volume":"5","author":"G Xu","year":"2014","unstructured":"Xu, G., Wang, J., Gao, G. F. & Liu, C. H. Insights into battles between Mycobacterium tuberculosis and macrophages. Protein Cell 5, 728\u2013736 (2014).","journal-title":"Protein Cell"},{"key":"67188_CR62","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1128\/MCB.01430-12","volume":"33","author":"A Apelbaum","year":"2013","unstructured":"Apelbaum, A., Yarden, G., Warszawski, S., Harari, D. & Schreiber, G. Type I interferons induce apoptosis by balancing cFLIP and caspase-8 independent of death ligands. Mol. Cell Biol. 33, 800\u2013814 (2013).","journal-title":"Mol. Cell Biol."},{"key":"67188_CR63","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3389\/fimmu.2014.00180","volume":"5","author":"T Prezzemolo","year":"2014","unstructured":"Prezzemolo, T. et al. Functional signatures of human CD4 and CD8 T cell responses to mycobacterium tuberculosis. Front Immunol. 5, 180 (2014).","journal-title":"Front Immunol."},{"key":"67188_CR64","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1097\/QAD.0b013e3283565ebe","volume":"26","author":"SD Lawn","year":"2012","unstructured":"Lawn, S. D., Gupta, A. & Wood, R. Assessing the impact of prevalent tuberculosis on mortality among antiretroviral treatment initiators: accurate tuberculosis diagnosis is essential. AIDS 26, 1730\u20131731 (2012).","journal-title":"AIDS"},{"key":"67188_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034156","volume":"7","author":"A Gupta","year":"2012","unstructured":"Gupta, A., Wood, R., Kaplan, R., Bekker, L. G. & Lawn, S. D. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community. PloS ONE 7, e34156 (2012).","journal-title":"PloS ONE"},{"key":"67188_CR66","doi-asserted-by":"publisher","first-page":"6740","DOI":"10.4049\/jimmunol.162.11.6740","volume":"162","author":"C Manca","year":"1999","unstructured":"Manca, C. et al. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J. Immunol. 162, 6740\u20136746 (1999).","journal-title":"J. Immunol."},{"key":"67188_CR67","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.3389\/fimmu.2019.02479","volume":"10","author":"K Dijkman","year":"2019","unstructured":"Dijkman, K. et al. Disparate tuberculosis disease development in macaque species is associated with innate immunity. Front. Immunol. 10, 2479 (2019).","journal-title":"Front. Immunol."},{"key":"67188_CR68","doi-asserted-by":"publisher","first-page":"e1001249","DOI":"10.1371\/journal.pgen.1001249","volume":"6","author":"LB Barreiro","year":"2010","unstructured":"Barreiro, L. B., Marioni, J. C., Blekhman, R., Stephens, M. & Gilad, Y. Functional comparison of innate immune signaling pathways in primates. PLoS Genet. 6, e1001249 (2010).","journal-title":"PLoS Genet."},{"key":"67188_CR69","doi-asserted-by":"publisher","first-page":"5254","DOI":"10.1172\/JCI125810","volume":"129","author":"AN Buc\u015fan","year":"2019","unstructured":"Buc\u015fan, A. N. et al. Mechanisms of reactivation of latent tuberculosis infection due to SIV coinfection. J. Clin. Invest. 129, 5254\u20135260 (2019).","journal-title":"J. Clin. Invest."},{"key":"67188_CR70","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/infdis\/jis102","volume":"205","author":"S Mehra","year":"2012","unstructured":"Mehra, S. et al. The Mycobacterium tuberculosis stress response factor SigH is required for bacterial burden as well as immunopathology in primate lungs. J. Infect. Dis. 205, 1203\u20131213 (2012).","journal-title":"J. Infect. Dis."},{"key":"67188_CR71","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/infdis\/jis778","volume":"207","author":"S Mehra","year":"2013","unstructured":"Mehra, S. et al. Granuloma correlates of protection against tuberculosis and mechanisms of immune modulation by Mycobacterium tuberculosis. J. Infect. Dis. 207, 1115\u20131127 (2013).","journal-title":"J. Infect. Dis."},{"key":"67188_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9533","volume":"6","author":"D Kaushal","year":"2015","unstructured":"Kaushal, D. et al. Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosis. Nat. Commun. 6, 8533 (2015).","journal-title":"Nat. Commun."},{"key":"67188_CR73","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41564-020-00841-4","volume":"6","author":"DK Singh","year":"2021","unstructured":"Singh, D. K. et al. Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets. Nat. Microbiol. 6, 73\u201386 (2021).","journal-title":"Nat. Microbiol."},{"key":"67188_CR74","doi-asserted-by":"crossref","unstructured":"Stammes, M. A. et al. Recommendations for standardizing thorax PET-CT in non-human primates by recent experience from macaque studies. Animals 11, 204 (2021).","DOI":"10.3390\/ani11010204"},{"key":"67188_CR75","doi-asserted-by":"publisher","first-page":"806","DOI":"10.4049\/jimmunol.1700231","volume":"199","author":"JT Mattila","year":"2017","unstructured":"Mattila, J. T. et al. Positron emission tomography imaging of macaques with tuberculosis identifies temporal changes in granuloma glucose metabolism and integrin \u03b14\u03b21-expressing immune cells. J. Immunol. 199, 806\u2013815 (2017).","journal-title":"J. Immunol."},{"key":"67188_CR76","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/s41385-021-00425-3","volume":"14","author":"S Sakai","year":"2021","unstructured":"Sakai, S. et al. Functional inactivation of pulmonary MAIT cells following 5-OP-RU treatment of non-human primates. Mucosal Immunol. 14, 1055\u20131066 (2021).","journal-title":"Mucosal Immunol."},{"key":"67188_CR77","doi-asserted-by":"crossref","unstructured":"Li, Q., Skinner, P. J., Duan, L. & Haase, A. T. A technique to simultaneously visualize virus-specific CD8+ T cells and virus-infected cells in situ. J. Vis. Exp. 1561 (2009).","DOI":"10.3791\/1561"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67188-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67188-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67188-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:07:48Z","timestamp":1768403268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67188-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67188"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67188-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4908400\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"16 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"499"}}